Products for Research Use Only

Olmutinib

CAT: 0026-B1218-25Size: 25 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0026-B1218-25Size:25 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Olmutinib (BI 1482694), is a third-generation epidermal growth factor receptor (EGFR) mutation-specific tyrosine kinase inhibitor (TKI). It inhibits both EGFR activating and T790M resistance mutations, while sparing wild-type EGFR. It has been investigated in Phase II clinical trials in patients with EGFR T790M mutation-positive non-small cell lung cancer (NSCLC), who developed resistance to earlier generations of EGFR tyrosine kinase inhibitor therapy.
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
36 months